Zobrazeno 1 - 10
of 2 049
pro vyhledávání: '"Figg William D"'
Autor:
Gandhy, Shruti U., Karzai, Fatima H., Bilusic, Marijo, McMahon, Sheri, Cordes, Lisa M., Marte, Jennifer, Weisman, Amy J., Perk, Timothy G., Lindenberg, Liza, Mena, Esther, Turkbey, Baris, Arlen, Philip M., Dahut, William L., Figg, William D., Choyke, Peter, Gulley, James L., Madan, Ravi A.
Publikováno v:
In European Urology Oncology August 2024 7(4):735-741
Publikováno v:
In Seminars in Oncology February-April 2024 51(1-2):19-24
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Journal of Hematology & Oncology, Vol 5, Iss 1, p 35 (2012)
Abstract Men with metastatic castration-resistant prostate cancer (mCRPC) carry poor prognosis despite the use of docetaxel-based regimens which has modest survival benefit shown by randomized clinical trials. Significant progress in the discovery of
Externí odkaz:
https://doaj.org/article/1026c934515d408cabd7ca30e5ccf92e
Autor:
Price Douglas K, Orlandini Cinzia, Crea Francesco, Sissung Tristan M, Chioni Aldo, Giovannetti Elisa, Pastina Ilaria, Cianci Claudia, Figg William D, Ricci Sergio, Danesi Romano
Publikováno v:
BMC Cancer, Vol 10, Iss 1, p 511 (2010)
Abstract Background The selection of patients according to key genetic characteristics may help to tailor chemotherapy and optimize the treatment in Castration-Resistant Prostate Cancer (CRPC) patients. Functional polymorphisms within the cytochrome
Externí odkaz:
https://doaj.org/article/57c853f963e440338c45028425f7f1de
Autor:
Yarchoan Robert, Baum Caitlin E, English Bevin C, Liewehr David, Venzon David, Kummar Shivaani, Dahut William L, Kohn Elise C, Danesi Romano, Sissung Tristan M, Jain Lokesh, Giaccone Giuseppe, Venitz Jürgen, Price Douglas K, Figg William D
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 29, Iss 1, p 95 (2010)
Abstract Background Hypertension (HT) and hand-foot skin reactions (HFSR) may be related to the activity of bevacizumab and sorafenib. We hypothesized that these toxicities would correspond to favorable outcome in these drugs, that HT and HFSR would
Externí odkaz:
https://doaj.org/article/b56f4a2af7dc487cb64bde7dedbc97cc
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 28, Iss 1, p 99 (2009)
Abstract Background Imatinib, a tyrosine kinase inhibitor currently approved for treatment of several malignancies, has been shown to be a substrate for multiple efflux-transporter proteins, including ABCB1 (P-glycoprotein) and ABCG2 (BCRP). The effe
Externí odkaz:
https://doaj.org/article/e883f51078fb44e19b279c1f09b59dec
Autor:
Richardson, William J., Zimmerman, Sara M., Reno, Annieka, Corvalan Cabanas, Natalia, Arisa, Oluwatobi, Rudloff, Udo, Figg, William D., Peer, Cody J.
Publikováno v:
In Journal of Chromatography B 30 May 2023 1224
Publikováno v:
In iScience 17 March 2023 26(3)